Medicare Enrolled
Dr. Venkata Emani, M.D.
Cardiovascular Disease · Stockton, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Emani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Emani?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Emani
Dr. Venkata Emani is a cardiovascular disease specialist in Stockton, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Emani performed 8,133 Medicare services across 4,060 unique beneficiaries.
Between the years covered by Open Payments, Dr. Emani received a total of $7,713 from 34 pharmaceutical and/or device companies across 343 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Emani is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 9% volume in CA
$7,713 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,133
Medicare services
Top 9% in CA for cardiovascular disease
4,060
Unique beneficiaries
$104
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~428 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,933 | $89 | $160 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
893 | $11 | $54 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
647 | $51 | $100 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
560 | $43 | $102 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
529 | $46 | $70 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
524 | $39 | $75 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
476 | $40 | $84 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
353 | $157 | $370 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
250 | $64 | $98 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
243 | $157 | $390 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 210 | $417 | $525 |
| Heart muscle strain imaging | 184 | $31 | $65 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
176 | $20 | $70 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
176 | $729 | $1,100 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
139 | $58 | $212 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle while at rest and during stress. |
105 | $1,249 | $2,300 |
| New patient office visit, complex (60-74 min) | 83 | $153 | $275 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
80 | $133 | $258 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
65 | $52 | $95 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
61 | $10 | $20 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
61 | $15 | $35 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
60 | $39 | $175 |
| Aminophylline injection, up to 250 mg Administration of aminophylline medication via injection for a dose of up to 250 mg. |
53 | $6 | $10 |
| Ultrasound guidance for blood vessel access Use of ultrasound imaging to help locate and access a blood vessel. This guidance assists healthcare providers in performing procedures such as inserting IV lines or drawing blood. |
37 | $11 | $25 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
36 | $189 | $570 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
35 | $67 | $100 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
35 | $73 | $115 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
30 | $359 | $795 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
28 | $106 | $170 |
| Cardiac catheterization | 25 | $212 | $442 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
19 | $135 | $200 |
| Radiologist review of arm or leg artery image A radiologist reviews images of the arteries in the arm or leg. This process involves analyzing the visual data to assess the blood vessels. |
16 | $66 | $83 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
11 | $65 | $169 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.4% high complexity
17.5% medium
77.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,713
Total received (2018-2024)
Avg $1,102/year across 7 years
Top 32% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
343
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,590 (98.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$123 (1.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,098
2023
$1,717
2022
$477
2021
$718
2020
$662
2019
$1,600
2018
$1,442
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Bayer Healthcare Pharmaceuticals Inc.
$169
Merck Sharp & Dohme LLC
$158
Novartis Pharmaceuticals Corporation
$151
E.R. Squibb & Sons, L.L.C.
$142
Amgen Inc.
$89
Kiniksa Pharmaceuticals International, plc
$83
Boehringer Ingelheim Pharmaceuticals, Inc.
$79
AstraZeneca Pharmaceuticals LP
$75
PFIZER INC.
$64
Janssen Pharmaceuticals, Inc
$46
Lexicon Pharmaceuticals, Inc.
$26
Actelion Pharmaceuticals US, Inc.
$14
Top 3 companies account for 43.6% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$1,121
Novartis Pharmaceuticals Corporation
$868
Amgen Inc.
$659
Medtronic, Inc.
$637
E.R. Squibb & Sons, L.L.C.
$579
Bayer Healthcare Pharmaceuticals Inc.
$431
AstraZeneca Pharmaceuticals LP
$426
Amarin Pharma Inc.
$377
SANOFI-AVENTIS U.S. LLC
$327
Bayer HealthCare Pharmaceuticals Inc.
$299
Merck Sharp & Dohme LLC
$260
PFIZER INC.
$238
Esperion Therapeutics, Inc.
$205
Medtronic Vascular, Inc.
$189
Boston Scientific Corporation
$183
Boehringer Ingelheim Pharmaceuticals, Inc.
$156
Kowa Pharmaceuticals America, Inc.
$126
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$102
Abbott Laboratories
$88
Kiniksa Pharmaceuticals International, plc
$83
Regeneron Healthcare Solutions, Inc.
$81
Baxter Healthcare
$39
Relypsa, Inc.
$38
Lexicon Pharmaceuticals, Inc.
$26
PORTOLA PHARMACEUTICALS, INC.
$24
ACIST MEDICAL SYSTEMS, INC.
$22
Alnylam Pharmaceuticals Inc.
$19
Novo Nordisk Inc
$19
Cardiovascular Systems Inc.
$17
Astellas Pharma US Inc
$17
Kiniksa Pharmaceuticals, Ltd.
$17
Lundbeck LLC
$16
Actelion Pharmaceuticals US, Inc.
$14
ABIOMED
$11
Top 3 companies account for 34.3% of all-time payments
Associated products mentioned in payments ›
ANDEXXA · ASSURITY · Adempas · Arcalyst · Assurity Pacemaker · BRILINTA · CAMZYOS · CHANTIX · CVI SYSTEMS · CardioMEMS HF System · Connectivity and Remote care · CoreValve Evolut · ELIQUIS · EMBLEM · ENTRESTO · FARXIGA · GALLANT · GENERAL THERAPIES · HeartWare HVAD · Hillrom - Cardiac Ambulatory Monitor · Impella · JARDIANCE · Kerendia · LEQVIO · LEXISCAN · LifeVest · Livalo · MICRA · MULTAQ · NEXLETOL · NORTHERA · ONPATTRO · OPSUMIT · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Peripheral Orbital Atherectomy System · RXI CONSUMABLES · Repatha · Reveal LINQ · Rybelsus · VERQUVO · Vascepa · Veltassa · Verquvo · WATCHMAN · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
37
Per 100K population
4.7
County median income
$88,531
Nearest hospital
ST JOSEPH'S MEDICAL CENTER OF STOCKTON
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Emani is a clinical cardiology specialist, with above-average Medicare volume (top 9% in CA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Emani experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Emani performed 1,933 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Emani receive payments from pharmaceutical companies?
Yes. Dr. Emani received a total of $7,713 from 34 companies across 343 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Emani's costs compare to other cardiologists in Stockton?
Dr. Emani's average Medicare payment per service is $104. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Emani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Stockton
Browse cardiologists in Stockton ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology